Clinical Trials Browser

Phase 2 × Dalteparin × Plasma cell × Clear all

NCT01518465 2017-11-29

Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma